• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

以铁氰化钾为光谱探针试剂测定酚磺乙胺的应用及等效性评估

Application and equivalence assessment for determining ethamsylate by using potassium ferricyanide as spectroscopic probe reagent.

作者信息

Liu Litao, Li Jing, Li Quanmin

机构信息

College of Chemistry and Environmental Science, Henan Normal University, Xinxiang, Henan 453007, PR China.

出版信息

Anal Sci. 2010;26(11):1163-7. doi: 10.2116/analsci.26.1163.

DOI:10.2116/analsci.26.1163
PMID:21079346
Abstract

In this paper, a novel method has been established to determine ethamsylate using potassium ferricyanide as a spectroscopic probe reagent. It has been demonstrated that Fe(III) is reduced to Fe(II) by ethamsylate, and that the formed Fe(II) reacts with potassium ferricyanide to form soluble prussian blue (KFe(III)[Fe(II)(CN)(6)]). Beer's law is obeyed in the range of 0.16 - 24.00 µg mL(-1) with the molar absorption coefficient of 2.1 × 10(4) L mol(-1) cm(-1). The detection limit (3 σ/k) is 0.11 µg mL(-1). This method has been successfully applied to determine ethamsylate in pharmaceutical and serum samples with satisfactory results, and presented quite satisfactory credibility during method equivalence assessment.

摘要

本文建立了一种以铁氰化钾为光谱探针试剂测定酚磺乙胺的新方法。结果表明,酚磺乙胺可将Fe(III)还原为Fe(II),生成的Fe(II)与铁氰化钾反应生成可溶性普鲁士蓝(KFe(III)[Fe(II)(CN)(6)])。在0.16 - 24.00 µg mL(-1)范围内符合比尔定律,摩尔吸收系数为2.1 × 10(4) L mol(-1) cm(-1)。检测限(3σ/k)为0.11 µg mL(-1)。该方法已成功应用于药物和血清样品中酚磺乙胺的测定,结果令人满意,且在方法等效性评估中具有相当令人满意的可信度。

相似文献

1
Application and equivalence assessment for determining ethamsylate by using potassium ferricyanide as spectroscopic probe reagent.以铁氰化钾为光谱探针试剂测定酚磺乙胺的应用及等效性评估
Anal Sci. 2010;26(11):1163-7. doi: 10.2116/analsci.26.1163.
2
Spectrophotometric determination of perphenazine with the detection system of potassium ferricyanide-Fe(III) in pharmaceutical and serum samples.在药物和血清样本中,采用铁氰化钾 - Fe(III) 检测系统分光光度法测定奋乃静。
Spectrochim Acta A Mol Biomol Spectrosc. 2009 Oct 1;74(2):307-11. doi: 10.1016/j.saa.2009.06.012. Epub 2009 Jun 16.
3
A novel visible spectrophotometric method for the determination of ethamsylate in pharmaceutical preparations and biological samples.一种测定药物制剂和生物样品中氨甲环酸的可见分光光度新方法。
Spectrochim Acta A Mol Biomol Spectrosc. 2010 Mar;75(3):1013-7. doi: 10.1016/j.saa.2009.12.039. Epub 2009 Dec 16.
4
Spectrophotometric determination of dopamine hydrochloride in pharmaceutical, banana, urine and serum samples by potassium ferricyanide-Fe(III).用铁氰化钾-Fe(III)分光光度法测定药物、香蕉、尿液和血清样品中的盐酸多巴胺。
Anal Sci. 2009 Dec;25(12):1451-5. doi: 10.2116/analsci.25.1451.
5
A simple and sensitive assay for ascorbate using potassium ferricyanide as spectroscopic probe reagent.一种使用铁氰化钾作为光谱探针试剂测定抗坏血酸的简单灵敏的方法。
Anal Biochem. 2009 May 1;388(1):40-6. doi: 10.1016/j.ab.2009.01.039. Epub 2009 Feb 3.
6
Kinetic spectrophotometric analysis of pantoprazole in commercial dosage forms.泮托拉唑在市售剂型中的动力学分光光度分析。
Anal Sci. 2006 Jul;22(7):983-8. doi: 10.2116/analsci.22.983.
7
Micellar-mediated extractive spectrophotometric determination of hydrogen sulfide/sulfide through Prussian Blue reaction: application to environmental samples.通过普鲁士蓝反应的胶束介导萃取分光光度法测定硫化氢/硫化物:应用于环境样品
Anal Sci. 2010 Jan;26(1):83-7. doi: 10.2116/analsci.26.83.
8
[Spectrophotometric determination of piroxicam using ferric ferricyanide as reagent].[以铁氰化铁为试剂分光光度法测定吡罗昔康]
Rev Med Chir Soc Med Nat Iasi. 2009 Jan-Mar;113(1):268-73.
9
Sensitive spectrophotometric determination of amlodipine and felodipine using iron(III) and ferricyanide.采用铁(III)和铁氰化物通过分光光度法灵敏测定氨氯地平和非洛地平。
Farmaco. 2003 Feb;58(2):141-8. doi: 10.1016/S0014-827X(02)00018-6.
10
Visible spectrophotometric method for amiodarone.胺碘酮的可见分光光度法
Rev Med Chir Soc Med Nat Iasi. 2012 Jan-Mar;116(1):330-5.